Your Notifications
All done, no notifications

About Dr. Rowan Miller

  • Dr Rowan Miller is an experienced Consultant Medical Oncologist specialising in gynaecological oncology and early-phase clinical trials, including ovarian, endometrial, and cervical cancers.
  • Her sub-specialist interests include novel therapies for gynaecological cancers and the use of genomics and biomarkers to guide personalised treatment.
  • She provides treatments including chemotherapy, targeted/biological therapy, immunotherapy, and participation in early-phase clinical trials.
  • She completed her undergraduate training at the University of Oxford and clinical training at Guy’s and St Thomas’ Hospitals, London; trained in Medical Oncology at University College London; was awarded a Cancer Research UK Fellowship; and attained a PhD from the Institute of Cancer Research.
  • She completed a fellowship at Dana-Farber Cancer Institute, Harvard University.
  • Dr Rowan Miller is a Consultant Medical Oncologist at University College London Hospitals (UCLH) and St Bartholomew’s Hospital, Barts Health NHS Trust.
  • She is actively involved in clinical trials and research projects across UCL and Barts Health.
  • She is a member of the ESMO Personalised Medicine and Translational Research Committee.
  • She has authored multiple peer-reviewed publications and contributes actively to clinical education and research presentations.

Conditions treated by Dr. Rowan Miller

  • Gynaecological Cancers.
  • Breast Cancer

Area of Interest

  • Medical Oncology
  • Gynae-Oncology

Qualification

  • MA in Physiology: University of Oxford, 2000.
  • MBBS: University of London, 2004.
  • MRCP: Membership of the Royal College of Physicians.
  • PhD

Work Experiences

    • Global Team of Board Certified Surgeons and Medical Specialists
    • Written Second Opinion report delivered within 5 days
    • Option to avail the Video Consultation with the Lead Doctor of the board

    Access Our most trusted Medical Second Opinion

    Required | alphabets and spaces
    Required | A valid, working email address
    Required | A valid contact

    Telemedicine Doctors

    Do you know?

    You can book a video consultation with Dr. Rowan Miller on our platform

    CERTIFICATIONS (2)

    • Fellowship at Dana-Farber Cancer Institute, Harvard University.
    • Cancer Research UK Fellowship

    MEMBERSHIPS (3)

    • European Society for Medical Oncology (ESMO): Member of the Personalised Medicine and Translational Research Committee.
    • National Cancer Research Institute (NCRI): Member
    • Membership of the Royal College of Physicians.

    RESEARCH PAPERS AND PUBLICATIONS (5)

    • Davis EJ, Martin-Liberal J, Kristeleit R, Cho DC, Blagden SP, Berthold D, Cardin DB, Vieito M, Miller RE et al. First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer 2022;10:e004235. doi:10.1136/jitc-2021-004235
    • Lee JM, Gao B, Miller R et al. A Phase 2 Study of Prexasertib (LY2606368) in Platinum Resistant or Refractory Recurrent Ovarian Cancer. Gynecologic Oncology. Sep 30;S0090-8258(22)01839-X.doi: 10.10
    • Miller RE, Elyashiv O, El-Shakankery KH and Ledermann JA. Ovarian cancer therapy: homologous recombination deficiency as a predictive biomarker of response to PARP inhibitors. Oncotargets 2022 15:1105-1117
    • Devlin MJ, Miller R, Laforets F et al. The tumour microenvironment of clear cell ovarian cancer. Cancer Immunol Res. 2022 Sep 12;CIR-22-0407.
    • Miller RE, El-Shakankery KH and Lee JY. PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies. J Gynecol Oncol. 2022 May;33(3):e44

    Share Your Experience about Dr. Rowan Miller

    PROCEDURES

    • Cervical Cancer Treatment
    • Chemotherapy
    • Immunotherapy
    • Ovarian Cancer Treatment
    • Uterine Cancer Treatment
    • Vulvar Cancer Treatment

    FREQUENTLY ASKED QUESTIONS

    Is Dr. Rowan Miller doing teleconsultation on the MediGence platform?

    Dr. Rowan Miller is available to teleconsult on the MediGence platform.

    How long is the consultation?

    The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

    How soon can the consultation be organised?

    We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

    Is a follow-up consultation included in the consultation price?

    No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

    How do I share my medical record with the doctor for review?

    The option to share your medical records is available between the steps of the form provided to you on the website.

    Can I schedule my procedure with the doctor after the consultation?

    Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, assisted by our case managers.

    Can you get an estimate for the procedure?

    Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

    FAQ's Related to Medical Oncologist

    What types of cancers are treated?

    Specialises in gynaecological cancers, including ovarian, endometrial, and cervical cancers.

    What treatments are offered?

    Provides chemotherapy, targeted/biological therapy, immunotherapy, and early-phase clinical trial treatments.

    Is there a focus on personalised therapy?

    Yes, treatments are guided by genomics and biomarker analysis to tailor therapy to individual patients.

    Are early-phase clinical trials available?

    Yes, the doctor leads and participates in multiple early-phase clinical trials for novel therapies in gynaecological cancers.

    Does the doctor contribute to research and publications?

    Yes, involved in national and international research projects and has authored several peer-reviewed publications.

    Is the doctor involved in professional education or committees?

    Yes, serves on the ESMO Personalised Medicine and Translational Research Committee and participates in training and mentoring within the oncology field.

    Reviewer

    Dr. Vihan Gautam

    BPT, MS in Healthcare Mgmt

    3 Years of Experience

    Dr. Vihan Gautam, a skilled physiotherapy consultant and leader, holds a Bachelor of Physiotherapy (2017–2021) from Rajiv Gandhi University and is completing an MSc in Healthcare Management at the University of London (2023–2024). He excelled as a department head, overseeing business development and operations to ensure patient care and operational efficiency. View More

    Author

    Alvina Hasan

    M.Pharm

    1 Year of Experience

    Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in the pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven pieces designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.. View More